CSIMarket Company Name, Ticker, Customers, else..
 
Qrons Inc   (QRON)
Other Ticker:  
 
 
Price: $0.1855 $0.03 19.139%
Day's High: $0.1855 Week Perf: -21.73 %
Day's Low: $ 0.19 30 Day Perf: -68.02 %
Volume (M): 1 52 Wk High: $ 0.37
Volume (M$): $ 0 52 Wk Avg: $0.26
Open: $0.19 52 Wk Low: $0.16



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 14
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Qrons Inc
Qrons Inc is a biotechnology company that focuses on developing novel therapeutics for treating brain disorders and injuries. They utilize proprietary technology to deliver therapeutics directly to the brain, aiming to address the limitations of current treatments. Qrons Inc is committed to advancing the field of regenerative medicine by researching and developing innovative solutions to improve patient outcomes.


   Company Address: 28-10 Jackson Avenue #26N Long Island City 11101 NY
   Company Phone Number: 945-2080   Stock Exchange / Ticker: QRON


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Qrons Inc

Qrons Inc: Unveiling the Enigmatic Secret Behind Its Financial Downturn until September 2023

As the stock market heads into the heart of the reporting season for July to September 2023, investors eagerly await updates from various companies. Among the reporting companies are several constituents from the Biotechnology & Pharmaceuticals sector, which has always captivated the market's attention with its potential for groundbreaking discoveries and remarkable growth.
One notable player that released its financial figures recently is Qrons Inc. The emerging growth corporation revealed an operating shortfall of $-0.439555 million for the fiscal period ending on September 30, 2023. While the company has yet to disclose its top-line results, it is worth considering the performance of Qrons Inc in the previous year to provide context for current outcomes. In the third quarter of 2022, the company reported an operating shortfall of $-0.022451 million.
Qrons Inc

Qrons Inc Shocks Investors with Lower-than-Expected Operating Loss of $-0.023418 Million, Signals Potential Recovery

Qrons Inc Faces Challenging Second Quarter of 2023, But Shows Signs of Recovery
In a surprising turn of events, Qrons Inc, a prominent player in the Biotechnology & Pharmaceuticals industry, reported an operating loss of $-0.023418 million during the April to June 30, 2023 reporting cycle. This was significantly lower than the operating loss of $-0.031064 million recorded during the same period in 2022. These results have caught investors off guard, who were not anticipating any modifications in revenue during this reporting cycle.
Emerging growth corporations like Qrons Inc constantly evolve their business strategies to remain competitive. With that said, there is no denying that the second quarter of 2023 has been somewhat challenging for the company. Qrons Inc announced a net loss of $-0.013 million, in stark contrast to the $0.072 million in profitability recorded in the second quarter of 2022. These contrasting figures signify that the company is undergoing a transitional phase as it navigates the development of its business strategy.
Qrons Inc

QRON Inc. Reports Promising Q1 2023 Results, Signaling Effective Strategic Measures and Positive Path to Profitability

Investors in Qrons Inc. are feeling bullish about the company's prospects following the release of its latest earnings report, covering the January to March 31 2023 period. While stockholders weren't expecting any significant revenue increases, the strong performance in operating loss has provided a welcome surprise.
QRONs' operating loss for the first quarter of 2023 was $-0.036942 million, which is an improvement from the previous year's figure of $-0.063556 million. This is certainly a positive development for the company, indicating that its leaders are executing well on their strategic plans and making progress towards profitability. It is evident that QRONs has taken bold and decisive action to optimize its operations and cut down on losses, a move that can be acknowledged and appreciated by investors.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com